Michael Chang

Michael Chang is the Vice President Operations at ALX Oncology, specializing in clinical-stage immuno-oncology therapies. With experience at companies such as Labrys Biologics and Limerick BioPharma, Michael has a strong background in project management and research and development. Prior to their current role, Michael held leadership positions at CV Therapeutics, Pfizer, and Agouron Pharmaceuticals. Michael completed their education at UCLA and has a Post-Doctoral Research Fellowship at UCSF Medical Center.